(Q45050380)
Statements
1 reference
Phase II study of feasibility of dose-dense FEC followed by alternating weekly taxanes in high-risk, four or more node-positive breast cancer (English)
1 reference
1 reference
Arti Hurria
1 reference
Katherine S Panageas
1 reference
Chau T Dang
1 reference
Gabriella M D'Andrea
1 reference
Maura N Dickler
1 reference
Andrew D Seidman
1 reference
Monica Fornier
1 reference
Maria Theodoulou
1 reference
Diana Lake
1 reference
Violante E Currie
1 reference
Clifford A Hudis
1 reference
1 September 2004
1 reference
1 reference
10
1 reference
17
1 reference
5754-5761
1 reference
Identifiers
1 reference
1 reference